GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
GSK to shut vaccine factory in Germany, putting 641 jobs at risk - Finance news and analysis from Global Banking & Finance Review
Finance

GSK to shut vaccine factory in Germany, putting 641 jobs at risk

Published by Global Banking & Finance Review

Posted on September 11, 2026

2 min read

· Last updated: September 11, 2026

Add as preferred source on Google

GSK to Shutter Dresden Vaccine Factory by 2027, Impacting 641 Jobs

Overview and Implications of the Dresden Factory Closure

By Puyaan Singh and Bhanvi Satija

Sept 11 (Reuters) - GSK said on Friday it will be shutting down a vaccine factory in Dresden, Germany, in the summer of 2027, citing decreasing demand for traditional egg-based flu vaccines.

The closure would put 641 jobs at risk, according to German trade union Industriegewerkschaft Bergbau, Chemie, Energie (IGBCE).

Key Details of the Closure

Here are more details:

Reasons for Shutting Down the Dresden Facility

• "With decreasing demand for traditional egg-based flu vaccines, meaning we have more capacity than we need, we've conducted a review of the viability of our two flu vaccines manufacturing sites in Dresden, Germany, and Ste-Foy, Canada," GSK said.

Consolidation of Operations

• "Following this, we have taken a difficult decision to consolidate operations at one site. We have selected the site in Canada, which can fully match anticipated future demand in a sustainable and competitive way."

Reactions from Trade Unions and Local Impact

• IGBCE said employees had been informed of the plans on Thursday and that both it and the plant's works council opposed the closure.

• Closing the plant could cost the eastern state of Saxony highly skilled industrial jobs and deprive Germany of important pharmaceutical manufacturing expertise, the union said.

Production and Future Vaccine Development

• The Dresden facility makes flu and hepatitis shots, GSK's website showed.

• GSK will advance its mRNA-based seasonal influenza vaccine candidate to a late-stage trial this month after mid-stage data showed it generated stronger immune responses than currently approved standard- and high-dose shots in younger and older adults.

Industry Context and Related Developments

• In a separate development, Volkswagen last week announced a radical restructuring plan that could lead to 50,000 additional job cuts worldwide and the closure of major factories in Germany, including three in Saxony.

(Reporting by Puyaan Singh in Bengaluru and Bhanvi Satija in London; Editing by Shreya Biswas)

Key Takeaways

  • The planned closure of GSK’s Dresden vaccine factory in summer 2027 will put 641 jobs at risk, according to German union IGBCE; the site produces influenza and hepatitis vaccines (tag24.de).
  • GSK cited decreasing demand for egg‑based flu vaccines as justification for consolidating manufacturing at its Ste‑Foy, Quebec site, which can sustainably meet future vaccine demand (tag24.de).
  • Global flu vaccine production remains steady overall—around 1.5 billion trivalent doses annually—but the market is shifting away from traditional egg‑based vaccines toward enhanced or cell‑based technologies (pmc.ncbi.nlm.nih.gov).

References

Frequently Asked Questions

Why is GSK shutting its vaccine factory in Dresden, Germany?
GSK is closing its Dresden factory due to decreasing demand for traditional egg-based flu vaccines.
How many jobs are at risk due to the GSK vaccine factory closure?
The closure is expected to put 641 jobs at risk, according to the German trade union IGBCE.
When will the GSK vaccine plant in Dresden close?
The factory is scheduled to close in the summer of 2027.
What vaccines are produced at the GSK Dresden facility?
The Dresden facility manufactures flu and hepatitis vaccines.
What will happen to GSK’s vaccine production after the closure?
GSK plans to consolidate operations at its Canadian site, which will handle future demand.

Tags

Related Articles

More from Finance

Explore more articles in the Finance category